Kenneth S. Cohen to Child, Preschool
This is a "connection" page, showing publications Kenneth S. Cohen has written about Child, Preschool.
Connection Strength
1.066
-
An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity. J Neurooncol. 2021 May; 152(3):567-572.
Score: 0.113
-
Management of pediatric and adult patients with medulloblastoma. Curr Treat Options Oncol. 2014 Dec; 15(4):581-94.
Score: 0.073
-
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol. 2013 Jun; 15(6):783-7.
Score: 0.065
-
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar; 13(3):317-23.
Score: 0.056
-
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group. Neuro Oncol. 2011 Apr; 13(4):410-6.
Score: 0.056
-
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. J Clin Oncol. 2023 04 01; 41(10):1921-1932.
Score: 0.032
-
Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected? J Neurooncol. 2002 Apr; 57(2):123-6.
Score: 0.030
-
Pediatric glial tumors. Curr Treat Options Oncol. 2001 Dec; 2(6):529-36.
Score: 0.030
-
Second surgery for recurrent pilocytic astrocytoma in children. Pediatr Neurosurg. 2001 May; 34(5):229-34.
Score: 0.029
-
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787.
Score: 0.028
-
Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg. 2000 Jan; 32(1):24-9.
Score: 0.026
-
Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clin Cancer Res. 2019 12 15; 25(24):7303-7311.
Score: 0.026
-
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors. Clin Cancer Res. 2019 12 15; 25(24):7294-7302.
Score: 0.026
-
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol. 2018 10 09; 20(11):1547-1555.
Score: 0.024
-
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217.
Score: 0.023
-
Association of Neuronal Injury in the Genu and Body of Corpus Callosum After Cranial Irradiation in Children With Impaired Cognitive Control: A Prospective Study. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1234-1242.
Score: 0.023
-
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol. 2017 Oct 19; 19(11):1542-1552.
Score: 0.022
-
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Pediatr Blood Cancer. 2017 Nov; 64(11).
Score: 0.022
-
A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation. Cancer. 2017 Jan 01; 123(1):161-168.
Score: 0.021
-
Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy. Childs Nerv Syst. 2016 Aug; 32(8):1425-30.
Score: 0.020
-
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. Neuro Oncol. 2016 10; 18(10):1442-50.
Score: 0.020
-
Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas. Eur J Radiol. 2016 Apr; 85(4):700-6.
Score: 0.020
-
Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol. 2014 Aug; 38(8):1058-70.
Score: 0.018
-
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol. 2014 Nov; 16(11):1554-9.
Score: 0.018
-
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol. 2014 Oct; 16(10):1408-16.
Score: 0.018
-
Apparent diffusion coefficient of pediatric cerebellar tumors: a biomarker of tumor grade? Pediatr Blood Cancer. 2013 Dec; 60(12):2036-41.
Score: 0.017
-
Hemorrhagic and ischemic stroke in children with cancer. Pediatr Neurol. 2013 Oct; 49(4):237-42.
Score: 0.017
-
Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1307-11.
Score: 0.016
-
Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol. 2013 Mar; 15(3):360-9.
Score: 0.016
-
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol. 2012 Nov; 124(5):627-41.
Score: 0.016
-
Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):421-7.
Score: 0.015
-
Magnetic resonance imaging features of meningiomas in children and young adults: a retrospective analysis. J Neuroradiol. 2012 Oct; 39(4):218-26.
Score: 0.015
-
Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors. Am J Surg Pathol. 2010 Dec; 34(12):1783-91.
Score: 0.014
-
Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol. 2010 Aug; 99(1):65-71.
Score: 0.013
-
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol. 2009 Jan 20; 27(3):385-9.
Score: 0.012
-
Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008 Aug; 51(2):245-50.
Score: 0.012
-
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer. 2007 Dec 01; 110(11):2535-41.
Score: 0.011
-
Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging. 2006 Feb; 23(2):99-107.
Score: 0.010
-
Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004 May; 63(5):441-9.
Score: 0.009
-
Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003 Mar; 25(3):198-203.
Score: 0.008
-
Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol. 2002 Jan; 12(1):36-44.
Score: 0.007
-
No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol. 2000 Jul; 35(1):80-2.
Score: 0.007
-
Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol. 2000 Jul-Aug; 3(4):346-52.
Score: 0.007
-
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov; 22(10):971-9.
Score: 0.006